Molecular Docking Study of alpha-Cyclodextrin With Psoralen: MDA-MB-231 Cancer Cell

Prasheena Russell S (1) , Steiny R P (2) , Prema Kumari J (3)
(1) Department of Chemistry, Scott Christian College, Nagercoil, Tamil Nadu 629001, India, India ,
(2) Department of Chemistry, Central University of Tamil Nadu, Thiruvarur, Tamil Nadu 610005, India, India ,
(3) Department of Chemistry, Scott Christian College, Nagercoil, Tamil Nadu 629001, India, India


Psoralen is an important bioactive component, isolated from the leaves of Ficus carica (Fig). Psoralen is proved to inhibit breast cancer cell growth and in tumor bearing mice the function of osteoblasts and osteoclasts is regulated. It is difficult to treat Triple-Negative Breast Cancer, a sub type of breast cancer. On treating Fig leaf extract, it is found that the leaf extract inhibits the proliferation of MDA-MB-231, which is a TNBC cell line, but not MCF10A cells, which is normal breast epithelial cell line. To increase the stability, solubility, volatility, it is beneficial to encapsulate natural products with α-Cyclodextrin (α-CD). Cyclodextrin constituted by 6 glucose units are termed as α-Cyclodextrin. Compared to host molecule guest: host inclusion complexes exhibit improved chemical or biological properties. Main aim of the study is interaction of Psoralen with α-CD and MDA-MB-231 Cancer cell with α-CD: Psoralen inclusion complex by molecular docking studies. 3D structures of Psoralen, α-CD and MDA-MB-231 cancer cell are obtained and docking is carried out using PatchDock server. Model which is highly favorable will have a high score. Energetically favorable and most probable structures of α-CD: Psoralen and MDA-MB-231 cancer cell: α-CD Psoralen inclusion complex has a score of 1762 and 6230 respectively.

Full text article

Generated from XML file


Carneiro, S., et al. 2019. Cyclodextrin drug inclusion complexes: Invivo and Invitro approaches. International Journal of Molecular Sciences, 20(3):642.

Chen, R., et al. 2002. Docking unbound proteins using shape complementarity, desolvation and electrostatics. Proteins: Structure, Function and Genetics, 47(3):281–294.

Comeau, S. R., et al. 2004. ClusPro: a fully automated algorithm for protein-protein docking. Nucleic Acids Research, 32(2):96–99.

Duhovny, D., et al. 2002. Efficient unbound docking of rigid molecules. Lecture Notes in Computer Science, 2452:185–200.

Inbar, Y., et al. 2005. Approaching the CAPRI challenge with an efficient geometry based docking. Proteins: Structure, Function, and Bioinformatics, 60(2):217–223.

Jones, G., et al. 1997. Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology, 267(3):727–748.

Kfoury, M., et al. 2016. Cyclodextrins as encapsulation material for flavors and aroma. Encapsulations, pages 127–192.

Rashid, A., et al. 2017. Extraction, isolation and spectral analysis of the psoralen compound from ficus carica linn leaves. Pharma Innovation, 6(11):730– 733.

Roselet, L. S., et al. 2017. Spectral characteristics and molecular docking studies of α-cd inclusion complex of 2-methyl 4-nitrophenol and 4-methyl 2-nitrophenol. International Research Journal of Engineering and Technology, 4(7):2198–2205.

Schneidman-Duhovny, D., et al. 2005. PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Research, 33(2):363–367.

Sebaaly, C., et al. 2018. Potential applications of cyclodextrin inclusion complexes, liposomes, and drug-in-cyclodextrin-in-liposome in food industry and packaging. Role of Materials Science in Food Bioengineering, pages 187–234.

Vakser, I. A., et al. 1999. A systematic study of low-resolution recognition in protein-protein complexes. Proceedings of the National Academy of Sciences, 96(15):8477–8482.

Zhang, C., et al. 1997. Determination of atomic desolvation energies from the structures of crystallized proteins. Journal of Molecular Biology, 267(3):707–726.

Zhang, Y., et al. 2018. Extracts and components of Ficus carica leaves suppress survival, cell cycle, and migration of triple-negative breast cancer MDA-MB-231 cells. OncoTargets and therapy, 2018(11):4377–4386.


Prasheena Russell S
Steiny R P
Prema Kumari J (Primary Contact)
Prasheena Russell S, Steiny R P, & Prema Kumari J. (2021). Molecular Docking Study of alpha-Cyclodextrin With Psoralen: MDA-MB-231 Cancer Cell. International Journal of Research in Pharmaceutical Sciences, 12(2), 978–981. Retrieved from

Article Details

No Related Submission Found